Diligence memo · auto-generated · as of July 2, 2026

Wave Life Sciences Pte Ltd

Wave Life Sciences Pte Ltd looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Wave Life Sciences Pte Ltd operates in Other Health Care, based in SINGAPORE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Wave Life Sciences Pte Ltd has raised $78M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $66M on 2015-08-14.

Most recent recorded round closed around 2015-08-14.

Valuation (modeled)modeled

Provath models Wave Life Sciences Pte Ltd at approximately $1.5B (range $240M–$4.0B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.32× the median modeled value of Series C Other Health Care companies in 2013–2015 (33 peers) — value vs value, same stage and era. Within the normal band (132% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 7 months.

Last raise 10.9 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 5.6× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 95% of Other Health Care peers (5377 compared).

Modeled value ranks above 98% of those peers.

Closest niche peers: ACON IWP Holdings, L.L.C., Erc Group Holdings, Llc, Cpf Senior Living Holdings, Llc, Corvus Pharmaceuticals, Inc., TVG-SHC Holdings, LLC.

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.